🧬 Genetic Disorder

Bardet-Biedl Syndrome

Also known as: BBS

Bardet-Biedl Syndrome (BBS) is a rare, genetically heterogeneous disorder characterized by a combination of clinical features, including retinal dystrophy, obesity, polydactyly, cognitive impairment, hypogonadism, and renal abnormalities. The severity and presence of these features can vary significantly among affected individuals.

👥 1 in 100,000 to 1 in 160,000 in Europe and North America; higher in certain isolated populations Prevalence
🔬 25 Active Trials

Imagine your body has tiny helpers that aren't working right. This can make it hard to see, cause you to gain weight easily, and sometimes you might have extra fingers or toes. It can also make learning a little tricky. Doctors can help with special glasses, healthy food, and extra help in school.

Signs & Symptoms

  • Retinal dystrophy (progressive vision loss)
  • Obesity
  • Polydactyly (extra fingers and/or toes)
  • Cognitive impairment
  • Hypogonadism (delayed or incomplete sexual development)
  • Renal abnormalities (kidney disease)
  • Learning difficulties
  • Speech delay
  • Behavioral problems
  • Diabetes mellitus
  • Hypertension
  • Congenital heart defects

Treatment Options

SUPPORTIVE

Low-vision aids and orientation/mobility training

SUPPORTIVE
SUPPORTIVE

Dietary management and exercise programs

MODERATELY EFFECTIVE
MEDICATION FDA Approved

Growth hormone therapy (for short stature)

MODERATELY EFFECTIVE
MEDICATION FDA Approved

Hormone replacement therapy (for hypogonadism)

HIGHLY EFFECTIVE
SURGERY

Dialysis or kidney transplantation (for renal failure)

HIGHLY EFFECTIVE
MEDICATION FDA Approved

Management of diabetes and hypertension

HIGHLY EFFECTIVE
THERAPY

Educational and behavioral therapies

MODERATELY EFFECTIVE
GENE THERAPY

Emerging Therapies Targeting Ciliary Dysfunction

EXPERIMENTAL

Diagnosis

  • Clinical evaluation based on the presence of primary features
  • Genetic testing to identify mutations in BBS genes
  • Ophthalmological examination (electroretinography)
  • Renal ultrasound
  • Assessment of cognitive function
  • Hormonal evaluation

History

Bardet-Biedl Syndrome was first described independently by Georges Bardet in 1920 and Arthur Biedl in 1922. They both reported families with the characteristic features of obesity, polydactyly, retinal dystrophy, and mental retardation.

Recent Breakthroughs

2022

Identification of Novel BBS Gene Mutations

Researchers identified new mutations in known BBS genes and potential candidate genes, expanding the genetic landscape of BBS and improving diagnostic capabilities.

2023

Development of Gene Therapy Approaches for BBS

Preclinical studies have shown promise for gene therapy approaches targeting specific BBS gene mutations, potentially restoring ciliary function and mitigating disease progression.